CHRS - Coherus BioSciences Inc
Coherus BioSciences Inc Logo

CHRS - Coherus BioSciences Inc

https://www.coherus.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-09 (Snapshot)

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.

52W High
$2.43
52W Low
$0.66
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.89
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
2.43
Forward P/E (<15 better)
41.15
EV/EBITDA (<8 favorable)
3.54
EV/Revenue (<3 favorable)
0.78
P/S (TTM) (<3 favorable)
0.55
P/B (<3 favorable)
1.25
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
6.52%
Institutions (25–75% balanced)
47.53%
Shares Outstanding
116,227,000
Float
111,186,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
272,209,000
Gross Profit (TTM)
151,856,000
EPS (TTM)
0.53
Profit Margin (>10% good)
0.66%
Operating Margin (TTM) (higher better)
-4.44%
ROE (TTM) (>15% strong)
0.33%
EPS YoY (Quarterly) (>10% good)
-0.76
Revenue YoY (Quarterly) (>8% good)
0.00
Momentum
Bearish momentum
Value
0.1070
Previous
0.1141
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025